Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice

Immunol Lett. 2023 Nov:263:113-122. doi: 10.1016/j.imlet.2023.10.005. Epub 2023 Oct 22.

Abstract

The role of inflammation in pulmonary hypertension is gradually gaining increasing research attention. However, no previous study has evaluated the characteristics of inflammation during chronic hypoxia-induced pulmonary hypertension. Therefore, the aim of this study was to investigate the characteristics of the inflammatory process involved in hypoxia-induced pulmonary hypertension in mice. The current study evaluated from day 4 to day 28 of hypoxia, the PAAT and PAAT/PET decreased, accompanied by pulmonary vascular remodeling and right ventricular hypertrophy, as well as increased numbers of CD68 macrophages. The expression of the pro-inflammatory factors IL-1β and IL-33 increased, but decreased on day 28. The expression of IL-12 increased from day 4 to day 28, whereas that of the anti-inflammatory factor IL-10 in lung tissue decreased. Furthermore, the expression of the IL-33/ST2 signaling pathway also increased over time under hypoxic conditions. In conclusion, pulmonary artery remodeling in HPH mice worsens progressively in a time-dependent manner, with inflammatory cell infiltration predominating in the early stage and pulmonary vascular remodeling occurring in the later stage.

Keywords: Hypoxic pulmonary hypertension; Immunomodulation; Immunotherapy; Macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hypertension, Pulmonary* / complications
  • Hypertension, Pulmonary* / metabolism
  • Hypoxia
  • Inflammation / complications
  • Interleukin-33
  • Macrophages / metabolism
  • Mice
  • Pulmonary Arterial Hypertension* / complications
  • Vascular Remodeling

Substances

  • Interleukin-33